It is not TGA-approved and has no approved indication in Australia
Investigational GLP-1 patches use specialised technologies such as microneedles to deliver large peptide molecules across the skin barrier
Glucagon-like peptide-1 (GLP-1) medications like semaglutide and tirzepatide, with brands such as Ozempic and Mounjaro, designed for diabetes, and Wegovy and Zepbound, designed for weight loss, have been soaring in popularity due to their effectiveness as weight loss aids
Both GLP-1 and GIP help the body produce more insulin post-meal
Acknowledgments The authors would like to thank SHRM, and particularly SHRM Tennessee and SHRM Austin, as well as the Midwest Business Group on Health, the NC Business Coalition on Health, and The Alliance for their assistance in organizing the focus groups
It means the benefit-risk profile must be proven through adequate trials, regulatory review, and continued safety monitoring